✦ LIBER ✦

Beneficial effect of interferon-β treatment in patients with multiple sclerosis is associated with transient increase in serum IL-6 level in response to interferon-β injection

✍ Scribed by Y. Nakatsuji; M. Nakano; M. Moriya; H. Kishigami; C. Tatsumi; S. Tada; S. Sadahiro; T. Naka; K. Mitani; M. Funauchi; T. Azuma; S. Watanabe; M. Kinoshita; K. Kajiyama; Y. Yuasa; M. Kaido; MP. Takahashi; I. Naba; T. Hazama; S. Sakoda

Book ID: 116397802
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 135 KB
Volume: 36
Category: Article
ISSN: 1043-4666
DOI: 10.1016/j.cyto.2006.10.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Beneficial effect of interferon-β 1b tre

Beneficial effect of interferon-β 1b treatment in patients with relapsing–remitting multiple sclerosis is associated with an increase in serum levels of soluble HLA-I molecules during the first 3 months of therapy

✍ Enrico Fainardi; Roberta Rizzo; Loredana Melchiorri; Massimiliano Castellazzi; V 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Quantitative analysis of interferon α/β

Quantitative analysis of interferon α/β receptor mRNA in the liver of patients with chronic hepatitis C: Correlation with serum hepatitis C virus-RNA levels and response to treatment with interferon

✍ HIROSHI YATSUHASHI; KAZUMI YAMASAKI; TOMOYUKI ARITOMI; PARQUET MARIA DEL CARMEN; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 617 KB

Preliminary study: Treatment with intram

Preliminary study: Treatment with intramuscular interferon beta-1a results in increased levels of IL-12Rβ2+and decreased levels of IL23R+CD4+T - Lymphocytes in multiple sclerosis

✍ Jennifer M Kress-Bennett; Garth D Ehrlich; Ashley Bruno; J Christopher Post; Fen 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 793 KB

SHORT-TERM TREATMENT OF RELAPSING REMITT

SHORT-TERM TREATMENT OF RELAPSING REMITTING MULTIPLE SCLEROSIS PATIENTS WITH INTERFERON (IFN)-β1B TRANSIENTLY INCREASES THE BLOOD LEVELS OF INTERLEUKIN (IL)-6, IL-10 AND IFN-γ WITHOUT SIGNIFICANTLY MODIFYING THOSE OF IL-1β, IL-2, IL-4 AND TUMOUR NECROSIS FACTOR-α

✍ Ferdinando Nicoletti; Roberto Di Marco; Francesco Patti; Paola Zaccone; Maria Ri 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 109 KB

CIRCULATING SERUM LEVELS OF IL-1ra IN PA

CIRCULATING SERUM LEVELS OF IL-1ra IN PATIENTS WITH RELAPSING REMITTING MULTIPLE SCLEROSIS ARE NORMAL DURING REMISSION PHASES BUT SIGNIFICANTLY INCREASED EITHER DURING EXACERBATIONS OR IN RESPONSE TO IFN-β TREATMENT

✍ Ferdinando Nicoletti; Francesco Patti; Roberto Di Marco; Paola Zaccone; Alessand 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 57 KB